Mikrobiomik

Mikrobiomik is a leading bio-pharmaceutical company dedicated to researching and developing innovative medicines based on the human microbiome. With a vision to be the first company to market a medicine based on fecal microbiota in the EU, Mikrobiomik is actively engaging with regulatory bodies like the EMA and AEMPS to establish clear protocols for securing Marketing Authorization Applications. Located at Parque Tecnológico de Bizkaia. Edificio BIC Bizkaia. Astondo Bidea, 612. Derio, Euskadi 48160, ES, Mikrobiomik is committed to pioneering therapeutic solutions that leverage the power of the human microbiome.

Mikrobiomik seeks to lead the paradigm shift in designing therapeutic solutions by focusing on excellence in its processes and empathizing with chronic patients who currently lack curative treatments. The company's approach is deeply rooted in networking with all stakeholders in the sector, fostering collaboration and driving innovation. Mikrobiomik's work in microbiome research and development promises significant advancements in patient care and treatment options.

With a strong focus on innovation and regulatory compliance, Mikrobiomik is poised to make a substantial impact on the bio-pharmaceutical industry. The company’s dedication to research and development, coupled with its strategic engagement with regulatory agencies, positions Mikrobiomik as a key player in the future of microbiome-based medicines. We invite the manager of Mikrobiomik to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.